P

The recent biotech stock market is really a tale of two extremes. CRSP and NTLA in hand are still struggling, chasing th…

The recent biotech stock market is really a tale of two extremes. CRSP and NTLA in hand are still struggling, chasing the dream of gene editing but completely missing the big surge of MLTX and ELVN, watching RVMD hit new highs again, feeling really sour. The ability to tell stories in a bull market is still there, but it's just a matter of whether it's your turn. Every time I think I'm holding onto faith, it turns into internal friction.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Author's posts

View more
  • How do investment gurus respond when the market falls?

    The father of growth stock value investing: In a continuously declining market, don't too quickly buy those unfamiliar stocks.

  • Howard Marks: How to Maintain a Good Investment Mindset?

    Howard: Our philosophy is to pursue a large number of reasonable successes while avoiding major failures
  • Charlie Munger: Control Primitive Irrational Emotions

    Successful investing is simple, but not easy.